Who we are:
We are a platform for sharing solutions to the biggest barriers facing health equity in drug development. Join our whole-ecosystem audience of pharmaceutical giants, biotechs, medtech, start-ups, CROs, sites, advocacy groups, patients, and academic excellence.
Who You Will Meet
Bringing together senior executives from large pharmaceutical and medical device companies, biotechs, startups, investors, CROs, patient advocacy groups, consultants, government representatives, regulatory experts, payers, non-profits, academic leaders and other supporting stakeholders, Health Equity in Clinical Trials Congress is dedicated to progressing industry alignment through collaboration and partnership whilst amplifying your DEI strategy.
Filter by:
Health Equity in Clinical Trials is being accelerated through the FDA’s requirement of Diversity Action Plans. We take pharmaceutical companies on a journey from upstream preclinical studies, data science and goal setting to, DEI strategy deployment, to post-study marketing. No matter what function you sit in your next collaborator sits in our network whether you are coordinating a study, reviewing protocols, on the lookout for new vendors, or here to learn.
Our Congress is Designed for leadership in the following pharmaceutical functions:
- DEI in Clinical Trials
- Clinical Operations
- Patient Engagement
- Patient Advocacy
- Regulatory Affairs
- Medical Affairs
- Medical Writing
- Data Science, RWE
- Epidemiology
- Corporate Affairs
- Marketing & Commercial